bar

Rathmell elected to ASCO nominating committee

W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee for the American Society of Clinical Oncology (ASCO). Read More

Telemedicine simplifies gestational diabetes treatment

When 32-year-old Dana Shaw was diagnosed with gestational diabetes mellitus (GDM) during her pregnancy with her first child, she was happy to learn she could meet with a physician about the condition through video conferencing rather than taking time off from work for an appointment. Read More

Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR T therapy

Vanderbilt-Ingram Cancer Center (VICC) has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy. Read More

VU scientists discuss cancer treatments, cellular dynamics

A trio of Vanderbilt University scientists described their cutting-edge investigations of cellular dynamics and cancer treatment during last week’s Flexner Discovery Lecture. Read More

New cutting-edge treatment for type of pediatric leukemia offered at Monroe Carell Jr. Children’s Hospital at Vanderbilt 

Monroe Carell Jr. Children’s Hospital at Vanderbilt is part of a select group of health care institutions recently chosen to offer a new FDA-approved immunotherapy… Read More

Hyundai Hope on Wheels award boosts pediatric cancer research

Adam Esbenshade, M.D., MSCI, assistant professor of Pediatrics in the Division of Pediatric Hematology/Oncology, has been awarded a $50,000 Hyundai Hope on Wheels Impact Award. Esbenshade plans to use data to create a risk prediction model to predict blood stream infections in pediatric cancer patients. Read More

Kidney cancer patient, survivor event set for Sept. 9

Vanderbilt-Ingram Cancer Center (VICC) will sponsor an educational conference for kidney cancer patients, survivors and family members Saturday, Sept. 9, 8 a.m. – 2 p.m., in the Preston Research Building, Suite 898. Read More

Awards honor dedication to excellence

The most recent Credo Award and Five Pillar Leader Award winners were announced at this week’s Clinical Enterprise Leadership Assembly at Langford Auditorium. The awards are conferred on a quarterly basis. Read More

Nashville Sounds partner with VICC for cancer awareness

The Nashville Sounds baseball team recently highlighted cancer care at Vanderbilt-Ingram Cancer Center (VICC) during a special “Cancer Awareness Night.” Read More

Hidden Epidemic

While survival rates continue to rise for children with once-fatal health conditions like brain tumors, leukemia and congenital heart disease, that survival comes at a cost: long-term, and sometimes permanent, learning deficits. Psychology and Human Development’s Bruce Compas has released a groundbreaking new study on the magnitude of this problem—and what can be done Read More

Patients with blood disorders invited to free June 24 seminar

Patients with aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH) and other blood disorders are invited to a free seminar featuring a Vanderbilt University Medical Center clinician and other medical experts. Read More

Proposals requested for St. Baldrick’s Foundation Fellowship Awards

Vanderbilt (VU and VUMC, collaboratively) may nominate one candidate for the 2018 St. Baldrick’s Foundation Fellowship Awards. Read More

Friends of Children’s Hospital gift to enhance two programs

The Friends of Children’s Hospital, an organization of volunteers who support Monroe Carell Jr. Children’s Hospital at Vanderbilt, has made its largest single gift — $1 million over three years — to be split between two Children’s Hospital programs: the Program for Children with Medically Complex Needs and Pediatric Cancer. Read More

Researchers seek best ways to increase HPV vaccination rates

Tennessee has one of the lowest human papillomavirus (HPV) vaccination rates in the nation, and investigators at Vanderbilt University Medical Center (VUMC) are hoping to change this by improving the way medical providers present these vaccines to patients and by improving patient and patient family education. Read More

Faculty meeting highlights VUMC’s achievements, goals

Vanderbilt University Medical Center (VUMC) is known for world-renowned research, national leadership in training health care professionals and for the most cutting-edge medical care for complex conditions. Read More

Lovly elected to American Society for Clinical Investigation

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt, has been elected to The American Society for Clinical Investigation (ASCI). Read More

Vanderbilt’s Christine Lovly elected to American Society for Clinical Investigation

  Christine Lovly, Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt University Medical Center (VUMC), has been elected… Read More

Vanderbilt’s W. Kimryn Rathmell named to ASCI leadership post

W. Kimryn Rathmell, director of the Division of Hematology/Oncology at Vanderbilt University Medical Center, has been named vice president of The American Society for Clinical Investigation. Read More

“U.S. News” Best Hospitals voting now open in Doximity

A message from Jeff Balser, M.D., Ph.D., President and CEO, VUMC, and Dean, Vanderbilt University School of Medicine; and C. Wright Pinson, MBA, M.D., Deputy CEO… Read More

Morton to help lead blood disorders treatment efforts

Colleen Morton, M.D., has joined Vanderbilt University Medical Center (VUMC) as section chief of Classical Hematology, a specialty also known as “benign hematology” because it covers all blood disorders that are not cancer. Read More